ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Study shows reduced hypoglycaemia after switch to Tresiba pharmatimes
March 12, 2019New data from Novo Nordisk has shown that people with type I or type II diabetes who were switched to Tresiba (insulin degludec) by their doctor from other basal insulins achieved significantly reduced rates of hypoglycaemia, along with reduction in blood -
Study shows reduced hypoglycaemia after switch to Tresiba pharmatimes
March 12, 2019New data from Novo Nordisk has shown that people with type I or type II diabetes who were switched to Tresiba (insulin degludec) by their doctor from other basal insulins achieved significantly reduced rates of hypoglycaemia, along with reduction in blood
Pharma Sources Insight January 2025
